Seftel, D., & Boulware, D. R. (2021). Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19. Open forum infectious diseases, 8(2), ofab050. https://doi.org/10.1093/ofid/ofab050
Chicago Style (17th ed.) CitationSeftel, David, and David R. Boulware. "Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19." Open Forum Infectious Diseases 8, no. 2 (2021): ofab050. https://doi.org/10.1093/ofid/ofab050.
MLA (9th ed.) CitationSeftel, David, and David R. Boulware. "Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19." Open Forum Infectious Diseases, vol. 8, no. 2, 2021, p. ofab050, https://doi.org/10.1093/ofid/ofab050.
Warning: These citations may not always be 100% accurate.